Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C.
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2013
At a glance
- Drugs Ademetionine (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 17 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov
- 17 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Apr 2010 Planned end date changed from 1 Feb 2009 to 1 Feb 2012 as reported by ClinicalTrials.gov.